Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000492885 | SCV000581996 | likely pathogenic | not provided | 2024-05-15 | criteria provided, single submitter | clinical testing | In silico analysis supports a deleterious effect on splicing; Has not been previously published as pathogenic or benign to our knowledge |
Fulgent Genetics, |
RCV002481563 | SCV002775955 | uncertain significance | Galloway-Mowat syndrome 1 | 2022-05-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000492885 | SCV002934466 | uncertain significance | not provided | 2023-10-13 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 6 of the WDR73 gene. It does not directly change the encoded amino acid sequence of the WDR73 protein. This variant is present in population databases (rs769933431, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with WDR73-related conditions. ClinVar contains an entry for this variant (Variation ID: 429429). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |